BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11068445)

  • 1. [Essential points to differentiate various diseases causing parkinsonism].
    Kuzuhara S
    Nihon Rinsho; 2000 Oct; 58(10):2049-53. PubMed ID: 11068445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Essential points to differentiate various diseases causing parkinsonism].
    Naito Y; Kuzuhara S
    Nihon Rinsho; 2004 Sep; 62(9):1608-16. PubMed ID: 15462373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson disease and its differentials. Diagnoses made easy.
    Chan DK
    Aust Fam Physician; 2001 Nov; 30(11):1053-6. PubMed ID: 11759455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Other causes of parkinsonism.
    Tison F
    Baillieres Clin Neurol; 1997 Apr; 6(1):205-18. PubMed ID: 9426876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A differential diagnosis of Parkinsonism.
    Weiner WJ
    Rev Neurol Dis; 2005; 2(3):124-31. PubMed ID: 16400311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnosis of manganese-induced parkinsonism.
    Cersosimo MG; Koller WC
    Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy.
    Wenning GK; Colosimo C
    Rev Neurol (Paris); 2010 Oct; 166(10):829-33. PubMed ID: 20813385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["Red flags": when to be alerted and how to explore?].
    Tison F
    Rev Neurol (Paris); 2010 Oct; 166(10):775-8. PubMed ID: 20817230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic criteria of parkinsonian syndromes].
    Tison F
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S19-23. PubMed ID: 12773884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy.
    Hussl A; Mahlknecht P; Scherfler C; Esterhammer R; Schocke M; Poewe W; Seppi K
    Mov Disord; 2010 Oct; 25(14):2444-9. PubMed ID: 20878992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
    Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A
    Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.
    Schulz JB; Skalej M; Wedekind D; Luft AR; Abele M; Voigt K; Dichgans J; Klockgether T
    Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Milestones in atypical and secondary Parkinsonisms.
    Wenning GK; Litvan I; Tolosa E
    Mov Disord; 2011 May; 26(6):1083-95. PubMed ID: 21626553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging.
    Savoiardo M
    Neurol Sci; 2003 May; 24 Suppl 1():S35-7. PubMed ID: 12774211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug-induced parkinsonism].
    Kuzuhara S
    Nihon Rinsho; 1997 Jan; 55(1):112-7. PubMed ID: 9014432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atypical parkinsonism].
    Tysnes OB; Vilming ST
    Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2077-80. PubMed ID: 18846125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
    Holmberg B; Rosengren L; Karlsson JE; Johnels B
    Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine transporter binding in chronic manganese intoxication.
    Huang CC; Weng YH; Lu CS; Chu NS; Yen TC
    J Neurol; 2003 Nov; 250(11):1335-9. PubMed ID: 14648150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease: clinical features.
    Quinn NP
    Baillieres Clin Neurol; 1997 Apr; 6(1):1-13. PubMed ID: 9426865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.